Enforcement and administrative action
Voluntary Recall disclosure naming ニザチジン製剤を製造販売する企業
The published name has not been matched to a verified Corporate Number. Check the identity before attributing this record to a company.
- Action type
- Voluntary Recall
- Law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- Authority
- Ministry of Health, Labour and Welfare
- Action date
- 3 December 2019
Published details
On December 3, 2019, voluntary recall initiated (Class I).
Machine-translated from the Japanese disclosure. The original Japanese text is available below.
Sources and saved materials
Review the source list, printable report and available saved files.
Evidence pack ¥4,980tax included · one-time purchase
Available PDFs, images and other files vary by record. Check the included materials before purchasing; a source URL does not guarantee an original file is included.
Purchase and download pages are currently in Japanese. Materials retain the original source language.
Official source URL recorded · Queued for preservation
Source links and saved files require purchase. Already purchased?
Action details
Show original Japanese text
※4令和元年12月3日、自主回収着手(クラスI)
Sources, saved materials and verification
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open Sources and saved materials on this page to review the available pack contents.
About this action and law
This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
English translations are for reference. Verify important decisions against the original Japanese disclosure. View the Japanese page.